{"disease":{"id":"immune-system-suppression","name":"immune system suppression"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05364411","title":"HYpofractionated, Dose-redistributed RAdiotherapy With Protons and Photons in HNSCC","phase":"NA","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Joris B.W. Elbers","has_results":false},{"nct_id":"NCT05655273","title":"Conversion of Maintenance Prograf to Envarsus in Liver Transplant Recipients","phase":"PHASE4","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":40,"lead_sponsor_name":"University Health Network, Toronto","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}